Zhongzhi Pharmaceutical Holdings Ltd 2020 AR2
The report highlights Zhongzhi Pharmaceutical Holdings Limited's performance and sustainability initiatives for the fiscal year 2020. The company achieved a revenue of RMB 1,603.9 million, representing a 19.5% increase compared to 2019. During the COVID-19 pandemic, the company donated medical supplies valued at RMB 7.1 million to support relief efforts. On the environmental front, the company reduced its total energy consumption intensity by 15% and water consumption intensity by 20% year-on-year. Additionally, its technology center was recognized as a National Enterprise Technology Center, marking a significant milestone in its scientific research.
Company: Zhongzhi Pharmaceutical Holdings Ltd
Sector: Health Care
Country: China
Year: 2020
Type: AR2
Pages: 183
Zhongzhi Pharmaceutical Holdings Ltd
Annual Report
The report highlights Zhongzhi Pharmaceutical Holdings Limited's performance and sustainability initiatives for the fiscal year 2020. The company achieved a revenue of RMB 1,603.9 million, representing a 19.5% increase compared to 2019. During the COVID-19 pandemic, the company donated medical supplies valued at RMB 7.1 million to support relief efforts. On the environmental front, the company reduced its total energy consumption intensity by 15% and water consumption intensity by 20% year-on-year. Additionally, its technology center was recognized as a National Enterprise Technology Center, marking a significant milestone in its scientific research.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees